← SynDRA
SAPROPTERIN
SynDRA canonical compound SYN0023616 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | TH |
| Mechanism of action | Phenylalanine 4-hydroxylase stimulant |
| Indication | hyperphenylalaninemia (HPA) |
| Disease area | metabolism |
All known targets
- PAH
- TH
- DBH
- NOS1
- NOS3
- TPH1
Mechanisms of action (all sources)
- Phenylalanine 4-hydroxylase stimulant
- PAH ACTIVATOR
- Phenylalanine-4-hydroxylase activator
- TH COFACTOR
- PAH MODULATOR
Drug classes
- P-Glycoprotein Inhibitors
- Breast Cancer Resistance Protein Inhibitors
- Phenylalanine Hydroxylase Activators
- Phenylalanine Hydroxylase Activator
ATC classes
- A16A · OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
Cross-references
Synonyms
- sapropterin hydrochloride
- tetrahydrobiopterin
- sapropterin dihydrochloride
- kuvan
- sapropterin HCl
- Sapropterine
- Sapropterina
- 6r-bh4
- Dapropterin
- R-thbp
- Tetrahydrobiopterin
- 5,6,7,8-tetrahydrobiopterin
- BRN 0544742
- CHEBI:15372
- 5,6,7,8-Tetrahydro-2-amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone
- L-erythro-2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-4(3H)-pteridinon
- (1R,2S)-(2-Amino-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)-1,2-propandiol
- 5,6,7,8-erythro-tetrahydrobiopterin
- 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydropteridin-4(3H)-one
- Phenoptin
- Sapropterin hydrochloride
- Biopten (TN)
- (6R)-L-erythro-tetrahydrobiopterin
- BH4
- 6R-BH4
- EGX657432I
- R-THBP
- Sapropterinum
- 6R-5,6,7,8-Tetrahydrobiopterin
- 6R-L-5,6,7,8-Tetrahydrobiopterin
- sapropterine
- (6R)-L-erythro-5,6,7,8-Tetrahydrobiopterin
- CHEBI:59560
- RefChem:56674
- A16AX07
- Sapropterin [INN]
- Sapropterin [MI]
- Sapropterin [VANDF]
Reported adverse events
- Headache
- Hypersensitivity
- Cough
- Nasal congestion
- Vomiting
Look up SAPROPTERIN in the interactive SynDRA portal →